Robert Ticktin
CIK 1613482 · General Counsel & COO · last filed 2026-03-09
Robert Ticktin is a General Counsel & COO who has filed 8 SEC Form 4 insider transactions across 2 companies since 2014. The most recent filing, for PMVP, was dated Mar 9, 2026. Across all open-market trades the lifetime net is −$13.5K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $109.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$109.6K
2
8
-$13.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | General Counsel & COO | 98,695 | $1.11 | $109.6K | -$24.7K | 2 | 2026-03-09 |
| EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | General Counsel | 3,949 | — | — | $11.2K | 6 | 2016-05-31 |
Recent Filings
8 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-09 | PMVP | Grant (A) | — | $0 | EDGAR |
| 2025-07-03 | PMVP | Sell (S) | −23,151 | -$24.7K | EDGAR |
| 2016-05-31 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-01 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Exer (M) | +3,083 | $0 | EDGAR |
| 2015-12-22 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Buy (P) | +3,000 | $11.2K | EDGAR |
| 2015-11-03 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-02 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-17 | EPIRUS Biopharmaceuticals, Inc. (EPRS) Delisted | Grant (A) | — | $0 | EDGAR |